Tumor growth kinetics, therapeutic differentials, and design of treatment schedules
Wheldon, T.E.; Brunton, G.F.
Cancer Treatment Reports 62(5): 845-847
1978
ISSN/ISBN: 0361-5960 PMID: 657169 Document Number: 124519
Document emailed within 1 workday
Related Documents
Fisher, B.; Gunduz, N. 1979: Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. X. Effect of treatment on tumor cell kinetics in mice Journal of the National Cancer Institute 62(6): 1545-1551Skipper, H.E. 1990: Tumor differences, drug differences, treatment design differences, and effects on therapeutic outcome (degree and duration of therapeutic response) Progress in Clinical and Biological Research 354a: 81-98
Norton, L. 1985: Tumor growth kinetics Mount Sinai Journal of Medicine new York 52(3): 161-164
Boranic, M. 1972: Chemotherapy of leukemia and kinetics of tumor growth Lijecnicki Vjesnik 94(9): 437-441
Páez Borda, A.; Angulo Frutos, J.; Luján Galán, M.; Llanes González, L.; Berenguer Sánchez, A. 1998: Kinetics of in vitro clonal growth of the murine MB-49 bladder tumor cell line Archivos Espanoles de Urologia 51(4): 319-324
Bardychev, D.M.; Ivanov, V.K. 1985: Mathematical modeling of the kinetics of a heterogeneous cell population during tumor growth. II. a numerical study and some generalizations Tsitologiia 27(1): 114-118
Barranco, S.C.; Townsend, C.M.; Costanzi, J.J.; May, J.T.; Baltz, R.; O'Quinn, A.G.; Leipzig, B.; Hokanson, K.M.; Guseman, L.F.; Boerwinkle, W.R. 1982: Use of 1,2:5,6-dianhydrogalactitol in studies on cell kinetics-directed chemotherapy schedules in human tumors in vivo Cancer Research 42(7): 2899-2905
Gasparini, G.; Pozza, F.; Meli, S.; Reitano, M.; Santini, G.; Bevilacqua, P. 1991: Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness Anticancer Research 11(6): 2015-2021
Principe, P.; Sidoti, C.; Coulomb, H.; Broquet, C.; Braquet, P. 1994: Tumor cell kinetics following long-term treatment with antineoplastic ether phospholipids Cancer Detection and Prevention 18(5): 393-400
Honda, T.; Gjertsen, B.T.; Spurgers, K.B.; Briones, F.; Lee, S.J.; Hobbs, M.L.; Meyn, R.E.; Roth, J.A.; Logothetis, C.; McDonnell, T.J. 2001: Restoration of bax in prostate cancer suppresses tumor growth and augments therapeutic cell death induction Anticancer Research 21(5): 3141-3146
Yoysungnoen, B.; Bhattarakosol, O.; Changtam, C.; Patumraj, S. 2016: Combinational Treatment Effect of Tetrahydrocurcumin and Celecoxib on Cervical Cancer Cell-Induced Tumor Growth and Tumor Angiogenesis in Nude Mice Journal of the Medical Association of Thailand 99 Suppl. 4: S23-S31
Sijens, P.E.; Bovee, W.M. 1988: In vivo 31P nuclear magnetic resonance spectroscopy of subcutaneous 9L gliosarcoma: effects of tumor growth and treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea on tumor bioenergetics and histology Cancer Research 48(19): 5610-5611
Konjević, G.; Jović, V.; Radulović, S.; Jelić, S.; Dzodić, R.; Spuzić, I. 2001: Therapeutic implications of the kinetics of immunomodulation during single or combined treatment of melanoma patients with dacarbazine and interferon-alpha Neoplasma 48(3): 175-181
Werther, K.; Nielsen, H.J. 2000: Significance of vascular endothelial growth factor--VEGF--in tumor angiogenesis. Therapeutic possibilities in solid tumors Ugeskrift for Laeger 162(37): 4916-4920
Cosić, S.J.; Kovac, Z. 2011: Clinical and etiopathogenetic role of plasminogen and metaloproteinase systems in the tumor growth. Pericellular proteolysis of extracellular matrix and tumor growth Lijecnicki Vjesnik 133(1-2): 56-63
Bethune, C.R.; Geyer, R.J.; Spence, A.M.; Ho, R.J. 2001: Lipid association improves the therapeutic index of lomustine [1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea] to suppress 36B-10 tumor growth in rats Cancer Research 61(9): 3669-3674
Ohnishi, K.; Bonavida, B. 1987: Regulation of Ia+ reticulum cell sarcoma (RCS) growth in syngeneic SJL/J mice. I. Inhibition of tumor growth by passive administration of L3T4 monoclonal antibody before or after tumor inoculation Journal of Immunology 138(12): 4524-4529
Duplessis, C.A.; Miller, J.C.; Crepeau, L.J.; Osborn, C.M.; Dyche, J. 2007: Submarine watch schedules: underway evaluation of rotating (contemporary) and compressed (alternative) schedules Undersea and Hyperbaric Medicine: Journal of the Undersea and Hyperbaric Medical Society Inc 34(1): 21-33
White, M.R.; Grendon, A.; Jones, H.B. 1970: Tumor incidence and cellularity in lungs of mice given various dose schedules of urethan Cancer Research 30(4): 1030-1036
Brenner, W.E.; Hendricks, C.H.; Braaksma, J.T.; Fishburne, J.I.; Staurovsky, L.G. 1972: Intra-amniotic administration of prostaglandin F 2 for induction of therapeutic abortion. a comparison of four dosage schedules Journal of Reproductive Medicine 9(6): 456-463